SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Evans Jason Eric

(Last)

(First)

(Middle)

1445 ROSS AVENUE

SUITE 1400

(Street)

DALLAS

75202

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/22/2016

3. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Pres. of Hospital Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3,072	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
2012 April Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock⁽²⁾	18,750	⁽¹⁾	D
2014 February Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock⁽²⁾	1,000	⁽³⁾	D
2015 February Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock⁽²⁾	2,334	⁽⁴⁾	D
2015 April Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock⁽²⁾	2,612	⁽⁵⁾	D
2016 March Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock⁽²⁾	7,844	⁽⁶⁾	D

Explanation of Responses:

1. These restricted stock units vest in full on April 30, 2017.

2. Restricted stock units are settled in shares of the Company's common stock upon vesting.

3. These restricted stock units vest in full on February 26, 2017.

4. Half of these restricted stock units vest on each of February 25, 2017 and 2018.

5. One-third of these time-based restricted stock units vest on each of April 30, 2016, 2017 and 2018.

6. One-third of these time-based restricted stock units vest on each of March 10, 2017, 2018 and 2019.

Remarks:

	Anthony L. Shoemaker, as Attorney-in-Fact for J. Eric Evans	04/01/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.